Investigation of the human FCRL1, 2, and 4 gene expressions in patients with rheumatoid arthritis

Expression Profile of Human Fc Receptor-Like 1, 2, and 4 Molecules in Peripheral Blood Mononuclear Cells of Patients with Hashimoto’s Thyroiditis and Graves’ Disease

(2015) D. Rostamzadeh et al.   HORMONE AND METABOLIC RESEARCH

Expression of FcRL4 defines a pro-inflammatory, RANKL-producing B cell subset in rheumatoid arthritis

(2014) L Yeo et al.   ANNALS OF THE RHEUMATIC DISEASES

Association of FCRL3 Genotypes with Susceptibility of Iranian Patients to Rheumatoid Arthritis

(2013) Hossein Golmoghaddam et al.   IMMUNOLOGICAL INVESTIGATIONS

Overexpression of Fc receptor-like 1 associated with B-cell activation during hepatitis B virus infection

(2012) Ke Wang et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

To B or Not to B the Conductor of Rheumatoid Arthritis Orchestra

(2012) Rita A. Moura et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Expression of human B-Cell specific receptor FCRL1 in healthy individuals and in patients with autoimmune diseases

(2012) K. O. Baranov et al.   MOLECULAR BIOLOGY

Juvenile rheumatoid arthritis and asthma, but not childhood-onset systemic lupus erythematosus are associated with FCRL3 polymorphisms in Mexicans

(2012) J. Ramírez-Bello et al.   MOLECULAR IMMUNOLOGY

Unknown

(2011) Alessandro Michelutti et al.   MOLECULAR MEDICINE

Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial

(2010) P. P. Tak et al.   ANNALS OF THE RHEUMATIC DISEASES

FcR-Like 2 Inhibition of B Cell Receptor-Mediated Activation of B Cells

(2010) T. A. Jackson et al.   JOURNAL OF IMMUNOLOGY

Alterations on peripheral blood B-cell subpopulations in very early arthritis patients

(2010) R. A. Moura et al.   RHEUMATOLOGY

FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia

(2009) Holger Nückel et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies

(2008) E Keystone et al.   ANNALS OF THE RHEUMATIC DISEASES

The Immunopathogenesis of Rheumatoid Arthritis

(2008) John B. Imboden   Annual Review of Pathology-Mechanisms of Disease

Low representation of Fc receptor-like 1–5 molecules in leukemic cells from Iranian patients with acute lymphoblastic leukemia

(2008) Tohid Kazemi et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Fc receptor-like 1-5 molecules are similarly expressed in progressive and indolent clinical subtypes of B-cell chronic lymphocytic leukemia

(2008) Tohid Kazemi et al.   INTERNATIONAL JOURNAL OF CANCER

The high producer variant of the Fc-receptor like-3 (FCRL3) gene is involved in protection against multiple sclerosis

(2008) Fuencisla Matesanz et al.   JOURNAL OF NEUROIMMUNOLOGY